Comments on: Multi-Omics Approaches to Validating Rasayana: Genomics, Proteomics, and Metabolomics

By: Megan Parker

Megan Parker — Mon, 19 Oct 2026 18:40:47 +0000

Overall the article makes a strong case that omics can reveal the systems level effects Ayurveda talks about.

Susan Clark — Thu, 15 Oct 2026 05:58:01 +0000

The mention of spatial metabolomics mapping tissue distribution sounds like a fascinating next step.

Tom Wilson — Sun, 11 Oct 2026 11:28:28 +0000

It’s interesting that the cholesterol related metabolite changes in chyawanprash align with improved lipid profiles.

Jessica Reed — Tue, 06 Oct 2026 19:09:13 +0000

The idea of using single cell omics to pinpoint cell specific effects could resolve many current uncertainties.

Emily Foster — Fri, 02 Oct 2026 16:26:14 +0000

I found the section on Nrf2 pathway activation across multiple rasayanas especially compelling.

Ashley Carter — Mon, 28 Sep 2026 19:06:17 +0000

The point about needing clinical outcome correlations is well taken; omics alone doesn’t prove disease prevention.

Laura Mitchell — Thu, 24 Sep 2026 12:00:07 +0000

Seeing the downregulation of NFkB in brahmi studies gives molecular support to its anti inflammatory reputation.

Nicole Hayes — Sun, 20 Sep 2026 01:28:32 +0000

The integrated multi omics approach described by the Ayurgenomics Initiative looks like a solid roadmap.

Rebecca Turner — Tue, 15 Sep 2026 21:39:06 +0000

I appreciate the discussion on batch to batch variability; standardized extracts would definitely help future studies.

Vikram Sharma — Sun, 13 Sep 2026 09:58:01 +0000

can someone with a strong Pitta constitution follow this or r modifications needed